[1]
Iannazzo, S. et al. 2008. Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy. Farmeconomia. Health economics and therapeutic pathways. 9, 3 (Sep. 2008), 125–135. DOI:https://doi.org/10.7175/fe.v9i3.225.